Literature DB >> 27761598

Seeing the sound after visual loss: functional MRI in acquired auditory-visual synesthesia.

Zixin Yong1, Po-Jang Hsieh2, Dan Milea3,4,5.   

Abstract

Acquired auditory-visual synesthesia (AVS) is a rare neurological sign, in which specific auditory stimulation triggers visual experience. In this study, we used event-related fMRI to explore the brain regions correlated with acquired monocular sound-induced phosphenes, which occurred 2 months after unilateral visual loss due to an ischemic optic neuropathy. During the fMRI session, 1-s pure tones at various pitches were presented to the patient, who was asked to report occurrence of sound-induced phosphenes by pressing one of the two buttons (yes/no). The brain activation during phosphene-experienced trials was contrasted with non-phosphene trials and compared to results obtained in one healthy control subject who underwent the same fMRI protocol. Our results suggest, for the first time, that acquired AVS occurring after visual impairment is associated with bilateral activation of primary and secondary visual cortex, possibly due to cross-wiring between auditory and visual sensory modalities.

Entities:  

Keywords:  Auditory-visual; Functional MRI; Ischemic optic neuropathy; Synesthesia

Mesh:

Substances:

Year:  2016        PMID: 27761598     DOI: 10.1007/s00221-016-4802-6

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  26 in total

1.  Visual stimuli activate auditory cortex in deaf subjects: evidence from MEG.

Authors:  Eva M Finney; Brett A Clementz; Gregory Hickok; Karen R Dobkins
Journal:  Neuroreport       Date:  2003-08-06       Impact factor: 1.837

2.  Sound-colour synaesthesia: to what extent does it use cross-modal mechanisms common to us all?

Authors:  Jamie Ward; Brett Huckstep; Elias Tsakanikos
Journal:  Cortex       Date:  2006-02       Impact factor: 4.027

Review 3.  Neurophysiology of synesthesia.

Authors:  Edward M Hubbard
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

4.  Melanocytoma of the optic nerve associated with sound-induced phosphenes.

Authors:  Ivana K Kim; Thaddeus P Dryja; Simmons Lessell; Evangelos S Gragoudas
Journal:  Arch Ophthalmol       Date:  2006-02

5.  Visual cortex activation in blind humans during sound discrimination.

Authors:  T Kujala; M Huotilainen; J Sinkkonen; A I Ahonen; K Alho; M S Hämäläinen; R J Ilmoniemi; M Kajola; J E Knuutila; J Lavikainen
Journal:  Neurosci Lett       Date:  1995-01-02       Impact factor: 3.046

6.  Auditory evoked phosphenes in optic nerve disease.

Authors:  N G Page; J P Bolger; M D Sanders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

Review 7.  Synesthesia: a new approach to understanding the development of perception.

Authors:  Ferrinne Spector; Daphne Maurer
Journal:  Dev Psychol       Date:  2009-01

8.  Acquired auditory-visual synesthesia: A window to early cross-modal sensory interactions.

Authors:  Pegah Afra; Michael Funke; Fumisuke Matsuo
Journal:  Psychol Res Behav Manag       Date:  2009-01-15

9.  Electrocorticography links human temporoparietal junction to visual perception.

Authors:  Michael S Beauchamp; Ping Sun; Sarah H Baum; Andreas S Tolias; Daniel Yoshor
Journal:  Nat Neurosci       Date:  2012-06-03       Impact factor: 24.884

Review 10.  The Merit of Synesthesia for Consciousness Research.

Authors:  Tessa M van Leeuwen; Wolf Singer; Danko Nikolić
Journal:  Front Psychol       Date:  2015-12-02
View more
  2 in total

1.  Neurophenomenology of induced and natural synaesthesia.

Authors:  David J Schwartzman; Daniel Bor; Nicolas Rothen; Anil K Seth
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-10-21       Impact factor: 6.237

2.  Functional MRI study in a case of Charles Bonnet syndrome related to LHON.

Authors:  V Vacchiano; C Tonon; M Mitolo; S Evangelisti; M Carbonelli; R Liguori; R Lodi; V Carelli; C La Morgia
Journal:  BMC Neurol       Date:  2019-12-30       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.